» Articles » PMID: 15921513

Variability and Conservation in Hepatitis B Virus Core Protein

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2005 Jun 1
PMID 15921513
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis B core protein (HBVc) has been extensively studied from both a structural and immunological point of view, but the evolutionary forces driving sequence variation within core are incompletely understood.

Results: In this study, the observed variation in HBVc protein sequence has been examined in a collection of a large number of HBVc protein sequences from public sequence repositories. An alignment of several hundred sequences was carried out, and used to analyse the distribution of polymorphisms along the HBVc. Polymorphisms were found at 44 out of 185 amino acid positions analysed and were clustered predominantly in those parts of HBVc forming the outer surface and spike on intact capsid. The relationship between HBVc diversity and HBV genotype was examined. The position of variable amino acids along the sequence was examined in terms of the structural constraints of capsid and envelope assembly, and also in terms of immunological recognition by T and B cells.

Conclusion: Over three quarters of amino acids within the HBVc sequence are non-polymorphic, and variation is focused to a few amino acids. Phylogenetic analysis suggests that core protein specific forces constrain its diversity within the context of overall HBV genome evolution. As a consequence, core protein is not a reliable predictor of virus genotype. The structural requirements of capsid assembly are likely to play a major role in limiting diversity. The phylogenetic analysis further suggests that immunological selection does not play a major role in driving HBVc diversity.

Citing Articles

NEDD4 family ubiquitin ligase AIP4 interacts with Alix to enable HBV naked capsid egress in an Alix ubiquitination-independent manner.

Shen S, Cai D, Liang H, Zeng G, Liu W, Yan R PLoS Pathog. 2024; 20(9):e1012485.

PMID: 39259704 PMC: 11389946. DOI: 10.1371/journal.ppat.1012485.


Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients.

Yuen M, Chuang W, Peng C, Jeng W, Su W, Chang T Clin Mol Hepatol. 2024; 30(3):375-387.

PMID: 38528825 PMC: 11261219. DOI: 10.3350/cmh.2023.0535.


Biology of the hepatitis B virus (HBV) core and capsid assembly modulators (CAMs) for chronic hepatitis B (CHB) cure.

McFadden W, Sarafianos S Glob Health Med. 2023; 5(4):199-207.

PMID: 37655181 PMC: 10461335. DOI: 10.35772/ghm.2023.01065.


PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine.

Dishlers A, Petrovskis I, Skrastina D, Zarina I, Lieknina I, Jansons J Microorganisms. 2023; 11(4).

PMID: 37110395 PMC: 10142831. DOI: 10.3390/microorganisms11040972.


Polymorphisms predicting phylogeny in hepatitis B virus.

Lourenco J, McNaughton A, Pley C, Obolski U, Gupta S, Matthews P Virus Evol. 2023; 9(1):veac116.

PMID: 36628296 PMC: 9825179. DOI: 10.1093/ve/veac116.


References
1.
Jones D, Taylor W, Thornton J . The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci. 1992; 8(3):275-82. DOI: 10.1093/bioinformatics/8.3.275. View

2.
Wong W, Yang Z, Goldman N, Nielsen R . Accuracy and power of statistical methods for detecting adaptive evolution in protein coding sequences and for identifying positively selected sites. Genetics. 2004; 168(2):1041-51. PMC: 1448811. DOI: 10.1534/genetics.104.031153. View

3.
Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht H . HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med. 1993; 177(3):751-62. PMC: 2190933. DOI: 10.1084/jem.177.3.751. View

4.
Thompson J, Higgins D, Gibson T . CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994; 22(22):4673-80. PMC: 308517. DOI: 10.1093/nar/22.22.4673. View

5.
Naoumov N, Thomas M, Mason A, Chokshi S, Bodicky C, Farzaneh F . Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment. Gastroenterology. 1995; 108(2):505-14. DOI: 10.1016/0016-5085(95)90080-2. View